SanaCurrents Introduction – Turn to the Biotech Experts to Maximize Your Returns

Introducing SanaCurrents It’s been 11 years since we launched GeoInvesting, [...]

ARMO Biosciences (ARMO) – SanaCurrents Case Study

ARMO Biosciences (ARMO) listed in January 2018 at $17 per [...]

Eiger Biopharmaceuticals (NASDAQ:EIGR) – SanaCurrents Case Study

Eiger Biopharmaceuticals (NASDAQ:EIGR), a company developing treatment for rare diseases, [...]

MyoKardia (NASDAQ:MYOK) – SanaCurrents Case Study

MyoKardia (NASDAQ:MYOK), a leading precision cardiovascular medicine company, reported good [...]

Dynavax’s (NASDAQ:DVAX) – SanaCurrents Case Study

Dynavax's (NASDAQ:DVAX) BLA application for its Hepatitis B vaccine first [...]

Zogenix (NASDAQ:ZGNX) – SanaCurrents Case Study

California-based company Zogenix (NASDAQ:ZGNX) observed the drug fenfluramine, which had [...]